Sign In
Buy CLAR
Clarus Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0200 |
| Revenue estimate | 61.219M |
| Revenue actual | 61.938M |
| Revenue Surprise | 1.17% |
| Release date | Mar 05, 2026 |
| EPS estimate | -$0.0233 |
| EPS actual | $0.0900 |
| EPS Surprise | 485.77% |
| Revenue estimate | 68.672M |
| Revenue actual | 65.413M |
| Revenue Surprise | -4.75% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0500 |
| EPS Surprise | -16.67% |
| Revenue estimate | 68.672M |
| Revenue actual | 69.347M |
| Revenue Surprise | 0.98% |
| Release date | Jul 31, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0300 |
| EPS Surprise | -200.00% |
| Revenue estimate | 53.494M |
| Revenue actual | 55.75M |
| Revenue Surprise | 4.22% |
Last 4 Quarters for Clarus
Below you can see how CLAR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $3.60 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0300 |
| EPS surprise | -200.00% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $3.93 |
| Jul 28, 2025 | $3.88 |
| Jul 29, 2025 | $3.79 |
| Jul 30, 2025 | $3.73 |
| Jul 31, 2025 | $3.60 |
| Aug 01, 2025 | $3.16 |
| Aug 04, 2025 | $3.25 |
| Aug 05, 2025 | $3.23 |
| Aug 06, 2025 | $3.15 |
| 4 days before | -8.40% |
| 4 days after | -12.50% |
| On release day | -12.22% |
| Change in period | -19.85% |
| Release date | Nov 06, 2025 |
| Price on release | $3.25 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0500 |
| EPS surprise | -16.67% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $3.34 |
| Nov 03, 2025 | $3.35 |
| Nov 04, 2025 | $3.30 |
| Nov 05, 2025 | $3.43 |
| Nov 06, 2025 | $3.25 |
| Nov 07, 2025 | $3.67 |
| Nov 10, 2025 | $3.60 |
| Nov 11, 2025 | $3.57 |
| Nov 12, 2025 | $3.45 |
| 4 days before | -2.69% |
| 4 days after | 6.15% |
| On release day | 12.92% |
| Change in period | 3.29% |
| Release date | Mar 05, 2026 |
| Price on release | $3.10 |
| EPS estimate | -$0.0233 |
| EPS actual | $0.0900 |
| EPS surprise | 485.77% |
| Date | Price |
|---|---|
| Feb 27, 2026 | $3.16 |
| Mar 02, 2026 | $3.26 |
| Mar 03, 2026 | $3.11 |
| Mar 04, 2026 | $3.17 |
| Mar 05, 2026 | $3.10 |
| Mar 06, 2026 | $2.99 |
| Mar 09, 2026 | $2.98 |
| Mar 10, 2026 | $3.04 |
| Mar 11, 2026 | $3.05 |
| 4 days before | -1.90% |
| 4 days after | -1.61% |
| On release day | -3.55% |
| Change in period | -3.48% |
| Release date | May 07, 2026 |
| Price on release | $2.89 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0200 |
| Date | Price |
|---|---|
| May 01, 2026 | $2.74 |
| May 04, 2026 | $2.60 |
| May 05, 2026 | $2.81 |
| May 06, 2026 | $2.94 |
| May 07, 2026 | $2.89 |
| May 08, 2026 | $3.01 |
| May 11, 2026 | $2.87 |
| May 12, 2026 | $2.63 |
| May 13, 2026 | $2.53 |
| 4 days before | 5.47% |
| 4 days after | -12.46% |
| On release day | 4.15% |
| Change in period | -7.66% |
Clarus Earnings Call Transcript Summary of Q1 2026
Key points for investors: Clarus reported Q1 2026 revenue of $61.9M, up 2.5% year-over-year, driven by strength in Black Diamond (Outdoor) and favorable wholesale in Australia for Adventure brands. Consolidated gross margin expanded to 36.8% (up ~240 bps year-over-year) as a result of improved product mix, less discounting, and price capture. Outdoor (Black Diamond) delivered solid results: core "big three" categories (mountain, climb, apparel) grew ~6.7% and now comprise >90% of Outdoor revenue; apparel grew double digits on a full-price basis and expanded distribution. Adventure (Rhino‑Rack, MAXTRAX, RockyMounts) showed revenue and gross margin improvement but faces a weak outlook in Australia; management now expects Adventure full‑year revenue to be ~$70M (down from prior $80M), reflecting retailer-led demand reductions tied to the Iran war, higher fuel and interest costs. As a result, Clarus revised 2026 guidance to revenue $245M–$255M and adjusted EBITDA $3M–$5M (previous guide $260M and $9M–$11M). Q1 adjusted EBITDA was reported as a $1.1M loss, but management noted it would have been a $0.3M positive if certain legal/regulatory costs were still treated as add-backs (they will no longer be). Cash was $29.8M and total debt was $0. Management continues simplification actions (restructuring, SKU/distribution rationalization) and cost controls; integration of MAXTRAX and Rhino‑Rack in Australia is underway. The Board has initiated a review of strategic alternatives (including potential sale of all or part of the business) to unlock shareholder value and has retained Jefferies. Key financial/operational items: potential tariff IEEPA credit ~ $6.2M (subject to approval); ongoing legal matters (Section 16(b) litigation, CPSC/DOJ investigation) with material quarterly legal expense assumptions (~$1M/quarter for remaining 2026); inventory $61.9M (up 10% YoY); free cash flow was negative $5.7M in Q1. Principal risks: prolonged Iran war raising factor costs and depressing consumer discretionary spending (especially in Australia), input/material inflation, tariff and regulatory outcomes, and legal exposures.
